Search research articles
Contact Us
Filters
Showing results (271-280 of 274) with videos related to
Page
of 28
Sort By:
You have reached the last page of results.
This site can display upto 274 results.
Antibiotics (Basel, Switzerland)
|
January 21, 2022
Effect of Different Piperacillin-Tazobactam Dosage Regimens on Synergy of the Combination with Tobramycin against <i>Pseudomonas aeruginosa</i> for the Pharmacokinetics of Critically Ill Patients in a Dynamic Infection Model
Jessica R Tait, Hajira Bilal, Kate E Rogers, et al.
Translational Psychiatry
|
March 8, 2017
Effects of naltrexone are influenced by childhood adversity during negative emotional processing in addiction recovery
G Savulich, R Riccelli, L Passamonti, et al.
The New England Journal of Medicine
|
October 4, 2018
Phase 2b Controlled Trial of M72/AS01<sub>E</sub> Vaccine to Prevent Tuberculosis
Olivier Van Der Meeren, Mark Hatherill, Videlis Nduba, et al.
The New England Journal of Medicine
|
October 30, 2019
Final Analysis of a Trial of M72/AS01<sub>E</sub> Vaccine to Prevent Tuberculosis
Dereck R Tait, Mark Hatherill, Olivier Van Der Meeren, et al.
Page
of 28
Search research articles
Search
Showing results (271-280 of 274) with videos related to
Sort By:
Page
of 28
You have reached the last page of results.
This site can display upto 274 results.
Antibiotics (Basel, Switzerland)
|
January 21, 2022
Effect of Different Piperacillin-Tazobactam Dosage Regimens on Synergy of the Combination with Tobramycin against <i>Pseudomonas aeruginosa</i> for the Pharmacokinetics of Critically Ill Patients in a Dynamic Infection Model
Jessica R Tait, Hajira Bilal, Kate E Rogers, et al.
Translational Psychiatry
|
March 8, 2017
Effects of naltrexone are influenced by childhood adversity during negative emotional processing in addiction recovery
G Savulich, R Riccelli, L Passamonti, et al.
The New England Journal of Medicine
|
October 4, 2018
Phase 2b Controlled Trial of M72/AS01<sub>E</sub> Vaccine to Prevent Tuberculosis
Olivier Van Der Meeren, Mark Hatherill, Videlis Nduba, et al.
The New England Journal of Medicine
|
October 30, 2019
Final Analysis of a Trial of M72/AS01<sub>E</sub> Vaccine to Prevent Tuberculosis
Dereck R Tait, Mark Hatherill, Olivier Van Der Meeren, et al.
Page
of 28